Free Trial
Your $100 Credit Expires Tomorrow! Get MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Cassava Sciences (FLNA) 10K Form and Latest SEC Filings 2026

Cassava Sciences logo
$1.31 +0.02 (+1.55%)
As of 05/22/2026 04:00 PM Eastern

Latest Cassava Sciences SEC Filings & Recent Activity

Cassava Sciences (NASDAQ:FLNA) has submitted 276+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Cassava Sciences's financial statements. The most recent filing was a Form 10-Q submitted on May 7, 2026.

8-K
Cassava Sciences Files Current Report on May. 7, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Cassava Sciences Files Quarterly Report on May. 7, 2026

The 10-Q contains Cassava Sciences's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Cassava Sciences SEC Filing History

Browse Cassava Sciences' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/07/2026 4:16 PM
Cassava Sciences (1069530) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 7:10 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2026 3:04 PM
Cassava Sciences (1069530) Filer
Form DEF 14A
04/28/2026 3:06 PM
Cassava Sciences (1069530) Filer
Form ARS
03/12/2026 7:15 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2026 7:15 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2026 7:15 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2025 7:46 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 3:09 PM
Cassava Sciences (1069530) Filer
Form 8-K/A
12/18/2025 4:02 PM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2025 3:12 PM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
PH: Do THESE 4 things to your bank account now … (Ad)

In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds. Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect.tc pixel

Discover all 4 steps to help protect your bank account now
12/07/2025 11:15 PM
Cassava Sciences (1069530) Filer
Form EFFECT
12/05/2025 3:49 PM
Cassava Sciences (1069530) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
12/03/2025 5:27 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2025 4:39 PM
Barry Richard (1562371) Reporting
Cassava Sciences (1069530) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 8:59 PM
Cassava Sciences (1069530) Filer
Form S-3
Registration statement under Securities Act of 1933  
11/12/2025 7:10 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2025 7:10 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 5:11 PM
Bir Dawn Carter (1688712) Reporting
Cassava Sciences (1069530) Issuer
Form 3
Initial statement of beneficial ownership of securities  
10/22/2025 5:15 PM
Bir Dawn Carter (1688712) Reporting
Cassava Sciences (1069530) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 7:12 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2025 3:44 PM
Cassava Sciences (1069530) Issuer
Cook Robert Christopher (1952028) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2025 3:06 PM
Barry Richard (1562371) Reporting
Cassava Sciences (1069530) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2025 8:15 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025 7:15 AM
Cassava Sciences (1069530) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2025 6:45 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025 6:45 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025 10:22 AM
Cassava Sciences (1069530) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
07/16/2025 6:02 PM
BlackRock, Inc. (2012383) Filed by
Cassava Sciences (1069530) Subject
Form SCHEDULE 13G/A
06/30/2025 6:15 AM
Cassava Sciences (1069530) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025 3:19 PM
Cassava Sciences (1069530) Issuer
Nicaise Claude (1644162) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025 3:21 PM
Cassava Sciences (1069530) Issuer
GUSSIN ROBERT Z (1245263) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025 3:23 PM
Cassava Sciences (1069530) Issuer
Gravier Pierre (1984065) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025 3:26 PM
Anderson Robert Eugene Jr (2001911) Reporting
Cassava Sciences (1069530) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025 3:17 PM
Cassava Sciences (1069530) Issuer
O DONNELL MICHAEL J (1245266) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Cassava Sciences SEC Filings - Frequently Asked Questions

Cassava Sciences (FLNA) has submitted 276+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Cassava Sciences's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Cassava Sciences's financial statements page.

The most recent filing was a Form 10-Q submitted on May 7, 2026. This was a quarterly financial update for 2025.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:FLNA) was last updated on 5/24/2026 by MarketBeat.com Staff.
From Our Partners